JP7227925B2 - Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate - Google Patents

Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate Download PDF

Info

Publication number
JP7227925B2
JP7227925B2 JP2019562062A JP2019562062A JP7227925B2 JP 7227925 B2 JP7227925 B2 JP 7227925B2 JP 2019562062 A JP2019562062 A JP 2019562062A JP 2019562062 A JP2019562062 A JP 2019562062A JP 7227925 B2 JP7227925 B2 JP 7227925B2
Authority
JP
Japan
Prior art keywords
pyrrole
fluorophenyl
group
formula
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019562062A
Other languages
Japanese (ja)
Other versions
JPWO2019131695A1 (en
Inventor
勲 大井
真 岩田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN SOPHARCHIM CO., LTD.
Nippon Chemiphar Co Ltd
Original Assignee
JAPAN SOPHARCHIM CO., LTD.
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN SOPHARCHIM CO., LTD., Nippon Chemiphar Co Ltd filed Critical JAPAN SOPHARCHIM CO., LTD.
Publication of JPWO2019131695A1 publication Critical patent/JPWO2019131695A1/en
Application granted granted Critical
Publication of JP7227925B2 publication Critical patent/JP7227925B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00Other general methods
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Description

本発明は、酸分泌抑制薬である1-[5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-イル]-N-メチルメタンアミンモノフマル酸塩及びその中間体の製造方法に関する。 The present invention provides an acid secretion inhibitor, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine mono It relates to a method for producing a fumarate salt and intermediates thereof.

下記式で示される1-[5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-イル]-N-メチルメタンアミンモノフマル酸塩(以下、ボノプラザンフマル酸塩)は、カリウムイオン競合型アシッドブロッカ-であり、カリウムイオンのH+,K±ATPaseへの結合を阻害し、胃酸分泌を抑制することから、胃・十二指腸潰瘍等の治療や予防、ヘリコバクタ-・ピロリ除菌時の胃内pH調整に用いられている。ボノプラザンフマル酸塩は既存のプロトンポンプインヒビタ-と比較して、酸に対して安定であり、有効濃度への到達が速やかで、服用から作用発現までが早く胃酸を長時間にわたって強く抑制することが知られている。 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate represented by the following formula (hereinafter , vonoprazan fumarate) is a potassium ion-competitive acid blocker that inhibits the binding of potassium ions to H +, K ± ATPase and suppresses gastric acid secretion, so it is used in the treatment of gastric and duodenal ulcers. It is used for the prevention of infection and for adjusting the intragastric pH when eradicating Helicobacter pylori. Compared to existing proton pump inhibitors, vonoprazan fumarate is stable against acid, reaches an effective concentration quickly, takes a short time from administration to manifestation of action, and strongly suppresses gastric acid over a long period of time. It is known.

Figure 0007227925000001
Figure 0007227925000001

ボノプラザンフマル酸塩の製造方法については、例えば特許文献1には、合成中間体であるピロ-ル-3-カルボキシアルデヒド誘導体について、下記式で示されるシアノ化合物からピロ-ル体を経て合成する方法が開示されている。 Regarding the method for producing vonoprazan fumarate, for example, in Patent Document 1, a pyrrole-3-carboxaldehyde derivative, which is a synthetic intermediate, is synthesized from a cyano compound represented by the following formula via a pyrrole form. A method for doing so is disclosed.

Figure 0007227925000002
Figure 0007227925000002

この方法では[2-(2-フルオロフェニル)-2-オキソエチル]プロパンジニトリル(a)を原料としている。この原料は、特許文献2記載の方法により製造できることが記載されており、臭化2-フルオロフェナシルからマロノニトリルの反応により合成することが開示されている。また、臭化2-フルオロフェナシルは、一般公知の方法により製造できることが記載されている。具体的な記載はないが、例えば酢酸中で臭素と反応させる方法(非特許文献1)や、塩化アルミニウムの存在下、臭素と反応させる方法などが知られている(非特許文献2)。原料の合成に2工程を要するため、目的化合物の製造に多工程が必要となる。またこれらの反応では、毒性や環境への影響が懸念されるマロノニトリルや腐食性、刺激性の強い臭素を必要とすることから、より人体及び環境への安全に配慮した製造方法が望まれる。また、5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドは、原料より収率53%~60%で合成されており、収率の改善も望まれる。
従って、人体や環境への影響の少なく、より短工程で収率の良い製造方法が望まれる。
In this method, [2-(2-fluorophenyl)-2-oxoethyl]propanedinitrile (a) is used as a starting material. It is described that this raw material can be produced by the method described in Patent Document 2, and it is disclosed that it is synthesized from 2-fluorophenacyl bromide by reacting malononitrile. It also describes that 2-fluorophenacyl bromide can be produced by a generally known method. Although there is no specific description, for example, a method of reacting with bromine in acetic acid (Non-Patent Document 1) and a method of reacting with bromine in the presence of aluminum chloride are known (Non-Patent Document 2). Since two steps are required to synthesize the raw materials, multiple steps are required to produce the desired compound. In addition, since these reactions require malononitrile and bromine, which is highly corrosive and irritating, which are concerned about toxicity and environmental impact, a production method that is more safe for the human body and the environment is desired. In addition, 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde is synthesized from raw materials with a yield of 53% to 60%, and an improvement in yield is desired.
Therefore, there is a demand for a production method which has less impact on the human body and the environment, which involves a shorter process and which has a high yield.

特許第5819494号公報Japanese Patent No. 5819494 特許第3140818号公報Japanese Patent No. 3140818

Organic Synthesis,Coll,Vol.1,127(1941)Organic Synthesis, Coll, Vol. 1,127 (1941) Organic Synthesis,Coll,Vol.2,480(1943)Organic Synthesis, Coll, Vol. 2,480 (1943) Synthesis, 49(16), 3692‐3699; 2017Synthesis, 49(16), 3692-3699; 2017 Journal of Organic Chemistry, 75(9), 3109‐3112; 2010Journal of Organic Chemistry, 75(9), 3109-3112; 2010

本発明は、ボノプラザンフマル酸塩の製造における合成中間体ピロ-ル-3-カルボキシアルデヒド誘導体の製造法及び当該誘導体を用いた新規なボノプラザンフマル酸塩の工業的製造法を提供することを目的とする。 The present invention provides a method for producing a synthetic intermediate pyrrole-3-carboxaldehyde derivative in the production of vonoprazan fumarate and a novel industrial production method for vonoprazan fumarate using the derivative. for the purpose.

本発明者らは鋭意検討を行った結果、入手容易なフルオロヨードベンゼンとピロールによるカップリング反応、およびピロ-ル環上窒素原子の適切な保護による位置選択的なホルミル化反応を用いることでピロ-ル-3-カルボキシアルデヒド誘導体を高収率かつ簡便に製造する方法を見出し、本発明を完成するに至った。 As a result of intensive studies, the present inventors have found that by using a coupling reaction with easily available fluoroiodobenzene and pyrrole and a regioselective formylation reaction by appropriately protecting the nitrogen atom on the pyrrole ring, The present inventors have found a method for producing a -ru-3-carboxaldehyde derivative in a high yield and in a simple manner, thereby completing the present invention.

すなわち
[1]本発明は、下記一般式(I)、
That is, [1] the present invention provides the following general formula (I),

Figure 0007227925000003
で表されるピロ-ル誘導体において、ピロ-ル環の窒素原子に保護基を導入し、
下記式(II):
Figure 0007227925000003
In the pyrrole derivative represented by, a protecting group is introduced to the nitrogen atom of the pyrrole ring,
Formula (II) below:

Figure 0007227925000004
(式中、Pは保護基を表す)で表されるN保護ピロ-ル誘導体を得、さらにホルミル化により下記式(III)
Figure 0007227925000004
(Wherein, P represents a protecting group) to obtain an N-protected pyrrole derivative represented by the following formula (III) by formylation

Figure 0007227925000005
で表されるピロ-ル-3-カルボキシアルデヒド誘導体を得、さらに脱保護反応により下記式(IV)
Figure 0007227925000005
To obtain a pyrrole-3-carboxaldehyde derivative represented by the following formula (IV) by further deprotection reaction

Figure 0007227925000006
で表される5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドの[2]また本発明は、前記Pで表される保護基が、シリル系保護基である前記[1]記載の製造方法に関するものである。
[3]また本発明は、前記Pで表される保護基が、トリイソプロピルシリル基である前記[1]又は[2]記載の製造方法に関するものである。
[4]また本発明は、前記一般式(I)のピロール誘導体が、
下記式(V):
Figure 0007227925000006
[2] of 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde represented by [2] The protecting group represented by P is a silyl-based protecting group [ 1] relates to the production method described above.
[3] The present invention also relates to the production method according to [1] or [2], wherein the protective group represented by P is a triisopropylsilyl group.
[4] The present invention also provides the pyrrole derivative of the general formula (I),
Formula (V) below:

Figure 0007227925000007
(式中、Lは脱離基を表す)で表されるオルトフルオロベンゼン誘導体を、金属触媒存在下、ピロ-ルと反応させることにより得られたものである前記[1]~[3]記載の化合物(I)の製造方法に関するものである。
[5]また本発明は、前記金属触媒がパラジウム触媒である前記[4]記載の製造方法に関するものである。
[6]また本発明は、前記製造方法により得られた一般式(IV)で表される5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドを、無機塩基または有機塩基の存在下、ピリジン-3-スルホニルクロリドまたはその塩と反応させ、
下記式(VI):
Figure 0007227925000007
(wherein L represents a leaving group), which is obtained by reacting an orthofluorobenzene derivative represented by with pyrrole in the presence of a metal catalyst, according to [1] to [3] above. It relates to a method for producing compound (I) of
[5] The present invention also relates to the production method according to the above [4], wherein the metal catalyst is a palladium catalyst.
[6] Further, the present invention provides 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde represented by the general formula (IV) obtained by the above-described production method with an inorganic base or an organic base. reacting with pyridine-3-sulfonyl chloride or a salt thereof in the presence of
Formula (VI) below:

Figure 0007227925000008
で表されるピロ-ル誘導体を得、さらにメチルアミンと縮合させた後、還元反応により、下記式(VII):
Figure 0007227925000008
to obtain a pyrrole derivative represented by the following formula (VII):

Figure 0007227925000009
で表される1-[5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-イル]-N-メチルメタンアミンの製造方法に関するものである。
[7]また本発明は、前記製造方法により得られた一般式(VII)の化合物とフマル酸による1-[5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-イル]-N-メチルメタンアミンモノフマル酸塩の製造方法に関するものである。
Figure 0007227925000009
It relates to a method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine represented by .
[7] The present invention also provides 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H produced by the compound of general formula (VII) obtained by the above production method and fumaric acid. -pyrrol-3-yl]-N-methylmethanamine monofumarate.

本発明は、ピロールや2-フルオロヨードベンゼンなどの入手容易な原料を用い、安価で短時間かつ短工程で5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドを良好な収率(70%以上)で得ることが可能であり、従来法よりも経済性及び生産性が高く工業的生産に適する。さらに遷移金属触媒の使用に関しても極少量に抑え、かつ上流工程で用いることで、より最終物への金属不純物残留に対する懸念を低減することが可能である。 The present invention uses readily available raw materials such as pyrrole and 2-fluoroiodobenzene, and produces 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde at a low cost in a short time and in a short process. It can be obtained with a high yield (70% or more), is more economical and more productive than conventional methods, and is suitable for industrial production. Furthermore, by limiting the amount of transition metal catalyst to be used and using it in the upstream process, it is possible to further reduce concerns about metal impurities remaining in the final product.

以下、本発明について更に詳細に説明する。
前記一般式(V)中、Lで表される脱離基としては、塩素、臭素、ヨウ素のハロゲン原子、メタンスルホニルオキシ基やトリフルオロメタンスルホニルオキシ基のような低級アルカンスルホニルオキシ基、ベンゼンスルホニルオキシ基やp-トルエンスルホニルオキシ基のようなアリールスルホニルオキシ基等を挙げることができる。
The present invention will be described in more detail below.
In the general formula (V), the leaving group represented by L includes halogen atoms of chlorine, bromine and iodine, lower alkanesulfonyloxy groups such as methanesulfonyloxy and trifluoromethanesulfonyloxy, and benzenesulfonyloxy. and an arylsulfonyloxy group such as a p-toluenesulfonyloxy group.

前記一般式(II)及び(III)中、Pで表されるピロ-ル環窒素保護基としては、シリル系保護基あるいはアルキル系保護基、ヘテロアリール系保護基、アシル系保護基、カ-バメ-ト系保護基等が挙げられ、シリル系保護基としてはトリメチルシリル基、トリエチルシリル基、tert-ブチルジメチルシリル基、トリイソプロピルシリル基、tert-ブチルジフェニルシリル基等が挙げられ、好ましくはtert-ブチルジメチルシリル基、トリイソプロピルシリル基等が挙げられる。
アルキル系保護基としてはアリル基、ジメトキシメチル基、ジエトキシメチル基、tert-ブチル基、トリフェニルメチル基、ベンジル基、4-メトキシベンジル基などが挙げられる。
ヘテロアリール系保護基としては2-ピリジル基、4-ピリジル基、2-ピラジル基、2-ピリミジル基、2-トリアジル基が挙げられる。
カ-バメ-ト系保護基としてはメトキシカルボニル基、エトキシカルボニル基、tert-ブトキシカルボニル基、tert-アミロキシカルボニル基、2,2,2-トリクロロエトキシカルボニル基、ベンジルオキシカルボニル基、p-クロロベンジルオキシカルボニル基、p-メトキシベンジルオキシカルボニル基、p-ニトロベンジルオキシカルボニル基、p-フェニルアゾベンジルオキシカルボニル基、p-メトキシフェニルアゾベンジルオキシカルボニル基、3,5-ジメトキシベンジルオキシカルボニル基、3,4,5-トリメトキシベンジルオキシカルボニル基、p-ビフェニルイソプロピルオキシカルボニル基、ジイソプロピルメチロキシカルボニル基、2-(トリメチルシリル)エトキシカルボニル基、9-フルオレニルメチルオキシカルボニル基等が挙げられる。
また、その他の保護基としてメタンスルホニル基等のアルキルスルホニル基、p-トルエンスルホニル基等のアリ-ルスルホニル基、アセチル基などのアルキルアシル基、ベンゾイル基などのアリールアシル基を用いることができる。
これらの保護基のうち、保護基としては収率等の点からシリル系保護基が好ましく、特に好ましくはトリメチルシリル基、トリエチルシリル基、tert-ブチルジメチルシリル基、トリイソプロピルシリル基が挙げられ、さらに好ましくはトリイソプロピルシリル基である。
In the general formulas (II) and (III), the pyrrole ring nitrogen protecting group represented by P includes a silyl protecting group, an alkyl protecting group, a heteroaryl protecting group, an acyl protecting group, a car Bamate-based protecting groups and the like, and silyl-based protecting groups include trimethylsilyl group, triethylsilyl group, tert-butyldimethylsilyl group, triisopropylsilyl group, tert-butyldiphenylsilyl group and the like, preferably tert. -Butyldimethylsilyl group, triisopropylsilyl group and the like.
Examples of alkyl protecting groups include allyl group, dimethoxymethyl group, diethoxymethyl group, tert-butyl group, triphenylmethyl group, benzyl group, 4-methoxybenzyl group and the like.
Heteroaryl protecting groups include 2-pyridyl, 4-pyridyl, 2-pyrazyl, 2-pyrimidyl and 2-triazyl groups.
Carbamate-based protective groups include methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, tert-amyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, benzyloxycarbonyl, p-chloro benzyloxycarbonyl group, p-methoxybenzyloxycarbonyl group, p-nitrobenzyloxycarbonyl group, p-phenylazobenzyloxycarbonyl group, p-methoxyphenylazobenzyloxycarbonyl group, 3,5-dimethoxybenzyloxycarbonyl group, 3,4,5-trimethoxybenzyloxycarbonyl group, p-biphenylisopropyloxycarbonyl group, diisopropylmethyloxycarbonyl group, 2-(trimethylsilyl)ethoxycarbonyl group, 9-fluorenylmethyloxycarbonyl group and the like.
As other protective groups, alkylsulfonyl groups such as methanesulfonyl group, arylsulfonyl groups such as p-toluenesulfonyl group, alkylacyl groups such as acetyl group, and arylacyl groups such as benzoyl group can be used.
Among these protecting groups, the protecting group is preferably a silyl-based protecting group from the viewpoint of yield and the like, particularly preferably a trimethylsilyl group, a triethylsilyl group, a tert-butyldimethylsilyl group and a triisopropylsilyl group. A triisopropylsilyl group is preferred.

本発明において、化合物(V)から化合物(I)を得る反応において用いられる金属触媒としては、ニッケル触媒やパラジウム触媒等を用いることができる。
本発明に用いられるニッケル触媒としては、ビス(1,5-シクロオクタジエニル)ニッケル等の0価のニッケル触媒、ニッケルクロリド、ビス(トリフェニルホスフィン)ニッケルクロリド等の2価のニッケル触媒等が挙げられ、必要に応じてトリフェニルホスフィン、2-(ジ-tert-ブチルホスフィノ)ビフェニル、Xantphos、ビス[2- (ジフェニルホスフィノ)フェニル]エーテル(以下、DPEPhos)、(±)-2,2’-ビス(ジフェニルホスフィノ)-1,1’-ビナフチル(以下、(±)-BINAP)等のホスフィン配位子、N,N,N’,N’-テトラメチルエチレンジアミン等を加えることができる。
本発明に用いられるパラジウム触媒としては、パラジウム炭素、テトラキストリフェニルホスフィンパラジウム等の0価のパラジウム触媒あるいは塩化パラジウム、酢酸パラジウム、(ジクロロビス(トリ-o-トリルホスフィン))パラジウム等の2価のパラジウム触媒が挙げられ、必要に応じてトリフェニルホスフィン、2-(ジ-tert-ブチルホスフィノ)ビフェニル、Xantphos、DPEPhos、(±)-BINAP等のホスフィン配位子等を加えることができる。
本発明に用いられる塩基としては、トリエチルアミン、ジイソプロピルエチルアミンなどの3級アミン、水素化リチウム、水素化ナトリウム、水素カリウム、ナトリウムアミド、リチウムジイソプロピルアミド(以下、LDA)、リチウムヘキサメチルジシラジド(以下、LiHMDS)、エチルマグネシウム、炭酸ナトリウム、炭酸カルシウムなどの金属塩基等を加えることができる。
In the present invention, a nickel catalyst, a palladium catalyst, or the like can be used as the metal catalyst used in the reaction for obtaining compound (I) from compound (V).
Examples of the nickel catalyst used in the present invention include zerovalent nickel catalysts such as bis(1,5-cyclooctadienyl)nickel, divalent nickel catalysts such as nickel chloride and bis(triphenylphosphine)nickel chloride. optionally triphenylphosphine, 2-(di-tert-butylphosphino)biphenyl, Xantphos, bis[2-(diphenylphosphino)phenyl]ether (hereinafter DPEPhos), (±)-2, A phosphine ligand such as 2'-bis(diphenylphosphino)-1,1'-binaphthyl (hereinafter referred to as (±)-BINAP), N,N,N',N'-tetramethylethylenediamine, etc. can be added. can.
The palladium catalyst used in the present invention includes zerovalent palladium catalysts such as palladium carbon and tetrakistriphenylphosphine palladium, or divalent palladium catalysts such as palladium chloride, palladium acetate, and (dichlorobis(tri-o-tolylphosphine))palladium. Catalysts can be mentioned, and if necessary, phosphine ligands such as triphenylphosphine, 2-(di-tert-butylphosphino)biphenyl, Xantphos, DPEPhos, (±)-BINAP and the like can be added.
Examples of bases used in the present invention include tertiary amines such as triethylamine and diisopropylethylamine, lithium hydride, sodium hydride, potassium hydrogen, sodium amide, lithium diisopropylamide (hereinafter LDA), lithium hexamethyldisilazide (hereinafter , LiHMDS), metal bases such as ethylmagnesium, sodium carbonate, calcium carbonate, and the like can be added.

本発明におけるボノプラザンフマル酸塩の製造における合成中間体ピロ-ル-3-カルボキシアルデヒド誘導体の製造法及び当該誘導体を用いたボノプラザンフマル酸塩の製造法を次に示す。 A method for producing a pyrrole-3-carboxaldehyde derivative, which is a synthetic intermediate in the production of vonoprazan fumarate in the present invention, and a method for producing vonoprazan fumarate using the derivative are described below.

Figure 0007227925000010
Figure 0007227925000010

(化合物(I)の製造)
化合物(I)は非特許文献3や非特許文献4に記載のクロスカップリング反応などにより製造することができる。例えば、根岸カップリング反応を用いることでハロゲン化されていない無置換のピロールを用いることができ、窒素又はアルゴン等の不活性ガス雰囲気下1~3当量の前述の塩基、好ましくは金属塩基、より好ましくは水素化ナトリウムのジエチルエ-テル、シクロプロピルメチルエ-テル、テトラヒドロフラン、4-メチルテトラヒドロピラン、ジオキサン、モノグライム、ジグライム等のエ-テル類;ベンゼン、トルエン、キシレン等の芳香族炭化水素類等の溶媒懸濁液に1~3当量のピロール/前記溶媒の溶液を-10℃~室温で滴下し10分~1時間撹拌した後、1~3当量のハロゲン化亜鉛(塩化亜鉛、臭化亜鉛)等の無機亜鉛、ジピバロイル亜鉛等の有機亜鉛(好ましくは、ハロゲン化亜鉛、特に好ましくは塩化亜鉛)を加え室温で10分~1時間攪拌する。次に、1~3当量の化合物(V)、0.0001~1.0当量(好ましくは0.001~0.003当量)のパラジウム等の前記触媒と0.0001~1.0当量(好ましくは0.001~0.003当量)の前記ホスフィン配位子を加え、室温~150℃(好ましくは90~130℃)で5分~24時間反応させることにより化合物(I)を製造することができる。
(Production of compound (I))
Compound (I) can be produced by the cross-coupling reaction described in Non-Patent Document 3 and Non-Patent Document 4, and the like. For example, non-halogenated unsubstituted pyrrole can be used by using a Negishi coupling reaction, and 1 to 3 equivalents of the above base, preferably a metal base, under an inert gas atmosphere such as nitrogen or argon. Ethers such as sodium hydride diethyl ether, cyclopropyl methyl ether, tetrahydrofuran, 4-methyltetrahydropyran, dioxane, monoglyme and diglyme; aromatic hydrocarbons such as benzene, toluene and xylene are preferred. 1 to 3 equivalents of pyrrole / solution of the above solvent was added dropwise at -10 ° C. to room temperature and stirred for 10 minutes to 1 hour, then 1 to 3 equivalents of zinc halide (zinc chloride, zinc bromide ), organic zinc such as dipivaloyl zinc (preferably zinc halide, particularly preferably zinc chloride) is added and stirred at room temperature for 10 minutes to 1 hour. Next, 1 to 3 equivalents of compound (V), 0.0001 to 1.0 equivalents (preferably 0.001 to 0.003 equivalents) of the catalyst such as palladium and 0.0001 to 1.0 equivalents (preferably is 0.001 to 0.003 equivalent) of the phosphine ligand and reacted at room temperature to 150° C. (preferably 90 to 130° C.) for 5 minutes to 24 hours to produce compound (I). can.

(化合物(II)の製造)
化合物(II)は化合物(I)に保護基を導入することにより製造することができ、保護基の導入は選択する保護基により製造方法は異なるが、一般公知の方法を採用することができる。例えばシリル系の保護基の導入にあっては、1~1.5当量の前述の塩基、好ましくは金属塩基、より好ましくは水素化ナトリウムのジエチルエ-テル、シクロプロピルメチルエ-テル、テトラヒドロフラン、4-メチルテトラヒドロピラン、ジオキサン、モノグライム、ジグライム等のエ-テル類又はN,N-ジメチルホルムアミド等の非プロトン性極性溶媒もしくはこれらの混合溶媒、好ましくはエーテル類等の溶媒懸濁液に、化合物(I)を-10℃~室温で滴下した後、クラウンエーテルやテトラエチレンジアミン、ジメチルイミダゾリジノン等の金属キレート剤、好ましくはジメチルイミダゾリジノンを加え、次いで1~1.5当量の保護基導入試薬を滴下し5分~3時間反応させることにより、化合物(II)を製造することができる。
また、カ-バメ-ト系保護基を導入する場合には、カ-バメート系保護基の種類により反応条件は異なるが、例えば化合物(I)に対しtert-ブトキシカルボニル(Boc基)、tert-アミロキシカルボニル(Aoc基)あるいはベンジルオキシカルボニル(Z基)、9-フルオレニルメチルオキシカルボニル(Fmoc)基、2,2,2-トリクロロエトキシカルボニル基、2-(トリメチルシリル)エトキシカルボニル基等を導入する場合には、ジオキサン、ジオキサン/水、塩化メチレン、テトラヒロドフラン等の溶媒中、トリエチルアミン、ピリジン等の有機塩基、水素化ナトリウム、水酸化カリウム、水酸化ナトリウム、炭酸水素カリウム、炭酸水素ナトリウム等の無機塩基の存在下、ジ-tert-ブチルジカルボネ-ト((Boc)O)やtert-ブトキシカルボニルクロリド、ベンジルオキシカルボニルクロリド、tert-アミロキシカルボニルクロリド、9-フルオレニルメチルオキシカルボニルクロリド、クロロギ酸2,2,2-トリクロロエチル 、2-(トリメチルシリル)エトキシメチルクロリド、tert-ブトキシカルボニルアジド、ベンジルオキシカルボニルアジド等の一般公知のBoc基等の導入試薬1~1.5当量を0℃~100℃で5分~10時間反応させることにより製造することができる。
(Production of compound (II))
Compound (II) can be produced by introducing a protecting group into compound (I). Although the production method for introducing the protecting group varies depending on the selected protecting group, a generally known method can be employed. For example, in the introduction of a silyl-based protecting group, 1 to 1.5 equivalents of the aforementioned base, preferably a metal base, more preferably sodium hydride diethyl ether, cyclopropyl methyl ether, tetrahydrofuran, 4 -Methyltetrahydropyran, dioxane, monoglyme, diglyme and other ethers or N,N-dimethylformamide and other aprotic polar solvents or mixed solvents thereof, preferably ethers, are added to a suspension of the compound ( After I) is added dropwise at -10°C to room temperature, a metal chelating agent such as crown ether, tetraethylenediamine, or dimethylimidazolidinone, preferably dimethylimidazolidinone, is added, and then 1 to 1.5 equivalents of a protecting group-introducing reagent is added. is added dropwise and reacted for 5 minutes to 3 hours to produce compound (II).
When a carbamate-based protecting group is introduced, the reaction conditions vary depending on the type of carbamate-based protecting group. amyloxycarbonyl (Aoc group) or benzyloxycarbonyl (Z group), 9-fluorenylmethyloxycarbonyl (Fmoc) group, 2,2,2-trichloroethoxycarbonyl group, 2-(trimethylsilyl)ethoxycarbonyl group, etc. When introducing, in a solvent such as dioxane, dioxane/water, methylene chloride, tetrahydrofuran, an organic base such as triethylamine or pyridine, sodium hydride, potassium hydroxide, sodium hydroxide, potassium hydrogen carbonate, hydrogen carbonate In the presence of an inorganic base such as sodium, di-tert-butyl dicarbonate ((Boc) 2 O), tert-butoxycarbonyl chloride, benzyloxycarbonyl chloride, tert-amyloxycarbonyl chloride, 9-fluorenylmethyloxycarbonyl 1 to 1.5 equivalents of an introduction reagent such as a generally known Boc group such as chloride, 2,2,2-trichloroethyl chloroformate, 2-(trimethylsilyl)ethoxymethyl chloride, tert-butoxycarbonyl azide, benzyloxycarbonyl azide, etc. It can be produced by reacting at 0° C. to 100° C. for 5 minutes to 10 hours.

(化合物(III)の製造)
化合物(III)は一般公知のホルミル化反応、例えばVilsmeier反応やRieche反応、Daff反応、Reimer―Tiemann反応などにより製造することができ、例えばVilsmeier反応ではN,N-ジメチルホルムアミド(DMF)、N-メチルホルムアニリド(MFA)、N-ホルミルモルホリン、N,N―ジイソプロピルホルムアミド等のN,N-二置換ホルムアミドとオキシ塩化リン、塩化オキサリル、塩化チオニル、トリフェニルホスフィン-臭素、ヘキサクロロトリホスファザトリエン等の酸塩化物からVilsmeier試薬((クロロメチレン)ジメチルイミニウムクロリド)を調製または市販品を購入し、これと化合物(II)を溶媒、例えばオキシ塩化リン;またはジクロロメタン、ジクロロエタン、クロロホルム、四塩化炭素、クロロベンゼン等のハロゲン化炭化水素類;ベンゼン、トルエン、ニトロベンゼン等の芳香族炭化水素類;テトラヒドロフラン、テトラメチルヒドロピラン、ジオキサン等のエーテル類又は酢酸エチル、アセトニトリル、N,N-ジメチルホルムアミド等の非プロトン性極性溶媒もしくはこれらの混合溶媒、好ましくはエーテル系溶媒、芳香族炭化水素類、非プロトン性極性溶媒もしくはこれらの混合溶媒、より好ましくはテトラメチルヒドロピラン中、0~100℃(好ましくは40~80℃)で0.5~12時間攪拌後反応させることにより、化合物(III)を製造することができる。
(Production of compound (III))
Compound (III) can be produced by a generally known formylation reaction such as Vilsmeier reaction, Rieche reaction, Daff reaction, Reimer-Tiemann reaction, etc. For example, Vilsmeier reaction uses N,N-dimethylformamide (DMF), N- N,N-disubstituted formamides such as methylformanilide (MFA), N-formylmorpholine, N,N-diisopropylformamide and phosphorus oxychloride, oxalyl chloride, thionyl chloride, triphenylphosphine-bromine, hexachlorotriphosphazatriene, etc. Prepare or purchase commercially available Vilsmeier reagent ((chloromethylene)dimethyliminium chloride) from the acid chloride of and combine this with compound (II) in a solvent such as phosphorus oxychloride; or dichloromethane, dichloroethane, chloroform, carbon tetrachloride. , chlorobenzene and other halogenated hydrocarbons; benzene, toluene, nitrobenzene and other aromatic hydrocarbons; tetrahydrofuran, tetramethylhydropyran, dioxane and other ethers or ethyl acetate, acetonitrile, N,N-dimethylformamide and other non- Protic polar solvents or mixed solvents thereof, preferably ether solvents, aromatic hydrocarbons, aprotic polar solvents or mixed solvents thereof, more preferably tetramethylhydropyran, in 0 to 100 ° C. (preferably 40 ~80°C) for 0.5 to 12 hours followed by reaction, compound (III) can be produced.

(化合物(IV)の製造)
化合物(IV)は化合物(III)の脱保護反応より製造することができる。脱保護反応は保護基により異なるが、一般公知の方法を用いることができ、例えば、保護基がシリル系保護基の場合には、テトラヒドロフラン等の溶液中-10℃~室温でテトラブチルアンモニウムフルオライドやHFピリジン錯体、HFトリエチルアミン錯体等のフッ素源を反応させることにより製造することができる。また、塩酸やトリフルオロ酢酸等の酸性条件下、水酸化ナトリウム水溶液等の塩基性条件下でも同様にシリル系保護基の脱保護反応が進行し、化合物(IV)を製造することができる。脱保護試薬は化合物(III)に対し3~10当量(好ましくは5当量)の水酸化ナトリウム水溶液を用いることができる。
また、カ-バメ-ト系の保護基の場合には、カ-バメ-ト系保護基の種類により反応条件は異なるが、一般公知の方法により行うことができ、例えば水素雰囲気下、パラジウム黒、パラジウム炭素等の存在下、接触還元により、あるいは酢酸/臭化水素、トリフルオロ酢酸、塩酸/有機溶媒等を保護基に合わせて適宜選択することにより行うことができる。
また化合物(IV)は化合物(II)から化合物(III)を単離することなくワンポットの操作で製造することができる。この場合、前記化合物(II)から化合物(III)の反応終了後、反応系中に前記脱保護のための試薬を加えることにより行うことができる。
また化合物(IV)は、化合物(I)から化合物(II)、化合物(III)を単離することなくワンポットの操作で製造することもでき、例えば前記化合物(III)の製造における反応終了後、その反応系に前記化合物(IV)の製造における反応試薬を加え、反応終了後、さらに反応系に上記脱保護反応のための試薬を加え、同様に反応させることにより、化合物(IV)を製造することができる。いずれの製造における試薬の量関係は、前記と同様の量を用いることができる。
(Production of compound (IV))
Compound (IV) can be produced from a deprotection reaction of compound (III). The deprotection reaction differs depending on the protecting group, but a generally known method can be used. , HF-pyridine complex, HF-triethylamine complex, or other fluorine source. In addition, the deprotection reaction of the silyl-based protecting group proceeds similarly under acidic conditions such as hydrochloric acid or trifluoroacetic acid, or under basic conditions such as aqueous sodium hydroxide solution, whereby compound (IV) can be produced. As a deprotecting reagent, 3 to 10 equivalents (preferably 5 equivalents) of sodium hydroxide aqueous solution can be used with respect to compound (III).
In the case of a carbamate-based protecting group, reaction conditions vary depending on the type of carbamate-based protecting group, but the reaction can be carried out by a generally known method. , catalytic reduction in the presence of palladium on carbon, etc., or by appropriately selecting acetic acid/hydrogen bromide, trifluoroacetic acid, hydrochloric acid/organic solvent, etc. according to the protective group.
Also, compound (IV) can be produced by a one-pot operation without isolating compound (III) from compound (II). In this case, after completion of the reaction of compound (II) to compound (III), the deprotection reagent can be added to the reaction system.
Compound (IV) can also be produced by a one-pot operation without isolating compound (II) and compound (III) from compound (I). A reaction reagent for the production of compound (IV) is added to the reaction system, and after completion of the reaction, a reagent for the deprotection reaction is further added to the reaction system and reacted in the same manner to produce compound (IV). be able to. As for the amount relationship of the reagents in any production, the same amount as described above can be used.

(化合物(VI)の製造)
1~1.5当量の水素化ナトリウム/テトラヒドロフランの懸濁液に-10℃~室温で化合物(IV)のテトラヒドロフラン等の溶液を滴下して加え、0.5~1時間撹拌した後、さらにクラウンエ-テルやテトラメチルエチレンジアミン、ジメチルイミダゾリジノン等の金属キレート剤の存在下、-10℃~室温で0.5~1時間攪拌し、続いてピリジン-3-スルホニルクロリドを加え、0℃で0.5時間攪拌する。さらにピリジン-3-スルホニルクロリドを加え、-10℃~室温で0.5~1時間撹拌することにより、化合物(VI)を製造することができる。
また化合物(VI)は、化合物(IV)のジクロロメタンやアセトニトリル等の溶液中、0℃~室温でトリエチルアミンやN,N-ジイソプロピルアミン等の塩基、触媒量の4-ジメチルアミノピリジン、ピリジン-3-スルホニルクロリドを添加し室温~100℃で0.5~12時間攪拌することにより製造することができる。
(Production of compound (VI))
A solution of compound (IV) in tetrahydrofuran or the like is added dropwise to a suspension of 1 to 1.5 equivalents of sodium hydride/tetrahydrofuran at −10° C. to room temperature, stirred for 0.5 to 1 hour, and then added with crown ethylenizer. - In the presence of a metal chelating agent such as tel, tetramethylethylenediamine, or dimethylimidazolidinone, the mixture is stirred at -10°C to room temperature for 0.5 to 1 hour, then pyridine-3-sulfonyl chloride is added, and the mixture is heated to 0°C at 0°C. Stir for 5 hours. Compound (VI) can be produced by further adding pyridine-3-sulfonyl chloride and stirring at -10°C to room temperature for 0.5 to 1 hour.
Further, compound (VI) can be prepared by adding a base such as triethylamine or N,N-diisopropylamine, a catalytic amount of 4-dimethylaminopyridine, pyridine-3- It can be produced by adding sulfonyl chloride and stirring at room temperature to 100° C. for 0.5 to 12 hours.

(化合物(VII)の製造)
化合物(VI)のメタノ-ル等の溶液に0℃~室温でメチルアミンのメタノ-ル等の溶液を滴下して加え、0.5~1時間攪拌し、これを0℃~室温で水素化ホウ素ナトリウム等の還元剤を1~3当量加え、0.5~1時間反応させることにより、化合物(VII)を得ることができる。
(Production of compound (VII))
A solution of methylamine in methanol or the like is added dropwise to a solution of compound (VI) in methanol or the like at 0°C to room temperature, stirred for 0.5 to 1 hour, and hydrogenated at 0°C to room temperature. Compound (VII) can be obtained by adding 1 to 3 equivalents of a reducing agent such as sodium boron and reacting for 0.5 to 1 hour.

(ボノプラザンフマル酸塩の製造)
化合物(VII)の酢酸エチル、メタノ-ル等の溶液に0℃~室温でフマル酸のメタノ-ル等の溶液を加え、0.5~1時間攪拌し、析出した結晶をろ取し、必要に応じてメタノール/水で再結晶することにより、ボノプラザンフマル酸塩を製造することができる。
(Production of vonoprazan fumarate)
A solution of fumaric acid in methanol or the like is added to a solution of compound (VII) in ethyl acetate or methanol at 0° C. to room temperature, and the mixture is stirred for 0.5 to 1 hour. Vonoprazan fumarate can be prepared by recrystallization with methanol/water according to .

以下に実施例、比較例および試験例により本発明をより詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES The present invention will be described in more detail with reference to Examples, Comparative Examples and Test Examples below, but the present invention is not limited to these.

実施例1
2-(2-フルオロフェニル)-1H-ピロ-ルの製造
水素化ナトリウム(60%流動パラフィンに分散、1.2g,30.0mmol)とテトラヒドロフラン(10mL)の懸濁液に氷冷下ピロ-ル(2.1mL,30.0mmol)を滴下し0.5時間撹拌した後、塩化亜鉛(4.1g,30.0mmol)を加え室温で0.5時間攪拌した。続いて酢酸パラジウム(11mg,0.05mmol)、2-(ジ-tert-ブチルホスフィノ)ビフェニル(15mg,0.05mmol)及び1-フルオロ-2-ヨ-ドベンゼン(1.1mL,10.0mmol)を加え脱気後、60℃で6時間撹拌した。反応混合物を0℃で冷却しつつ水を滴下し、不溶物をろ過した後、酢酸エチルで分液した。水層に酢酸エチルを加え再度抽出した後、有機層を合わせ飽和食塩水で洗浄した。減圧下溶媒を留去後、シリカゲルカラムクロマトグラフィ-で精製し減圧下乾燥することにより表題化合物(1.18g,収率74%)を得た。
Example 1
Preparation of 2-(2-fluorophenyl)-1H-pyrrole To a suspension of sodium hydride (dispersed in 60% liquid paraffin, 1.2 g, 30.0 mmol) and tetrahydrofuran (10 mL), pyro-pyrrole was added under ice-cooling. (2.1 mL, 30.0 mmol) was added dropwise and stirred for 0.5 hours, then zinc chloride (4.1 g, 30.0 mmol) was added and stirred at room temperature for 0.5 hours. followed by palladium acetate (11 mg, 0.05 mmol), 2-(di-tert-butylphosphino)biphenyl (15 mg, 0.05 mmol) and 1-fluoro-2-iodobenzene (1.1 mL, 10.0 mmol) was added, and after degassing, the mixture was stirred at 60°C for 6 hours. Water was added dropwise to the reaction mixture while cooling it at 0° C., insoluble matter was filtered, and the mixture was separated with ethyl acetate. Ethyl acetate was added to the aqueous layer and extracted again, and then the organic layers were combined and washed with saturated brine. After evaporating the solvent under reduced pressure, the residue was purified by silica gel column chromatography and dried under reduced pressure to obtain the title compound (1.18 g, yield 74%).

Mass(ESI):m/zcalcdforC10H7FN[M-H]-:160.06;found:160.18;1H-NMR(400MHz,CDCl3)δ(ppm):6.30-6.33(m,1H),6.64-6.67(m,1H),6.90-6.93(m,1H),7.07-7.16(m,1H),7.13-7.17(m,2H),7.60-7.65(m,1H),9.05(brs,1H). Mass (ESI): m / zcalcdfor C10H7FN [MH]-: 160.06; found: 160.18; 1H-NMR (400MHz, CDCl3) δ (ppm): 6.30-6.33 (m, 1H) , 6.64-6.67 (m, 1H), 6.90-6.93 (m, 1H), 7.07-7.16 (m, 1H), 7.13-7.17 (m, 2H), 7.60-7.65 (m, 1H), 9.05 (brs, 1H).

実施例2
2-(2-フルオロフェニル)-1-(トリイソプロピルシリル)-1H-ピロ-ルの製造
水素化ナトリウム(60%流動パラフィンに分散,64mg,1.61mmol)とテトラヒドロフラン(2mL)の懸濁液に氷冷下2-(2-フルオロフェニル)-1H-ピロ-ル(172mg,1.07mmol)のテトラヒドロフラン(2mL)溶液を滴下し0.5時間撹拌した後、15-クラウン-5-エ-テル(0.32mL,1.61mmol)を加え0℃で0.5時間攪拌した。続いてトリイソプロピルシリルクロリド(0.35mL,1.61mmol)を滴下し室温で4時間撹拌した。0℃まで冷却し水を滴下し酢酸エチルで分液した。水層に酢酸エチルを加え再度抽出した後、有機層を合わせ飽和食塩水で洗浄した。減圧下溶媒を留去後、シリカゲルカラムで精製し減圧下乾燥することにより表題化合物(272mg,収率80%)を得た。
Example 2
Preparation of 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole Suspension of sodium hydride (dispersed in 60% liquid paraffin, 64 mg, 1.61 mmol) and tetrahydrofuran (2 mL) A solution of 2-(2-fluorophenyl)-1H-pyrrole (172 mg, 1.07 mmol) in tetrahydrofuran (2 mL) was added dropwise to the solution under ice cooling, and the mixture was stirred for 0.5 hour. Teru (0.32 mL, 1.61 mmol) was added and the mixture was stirred at 0° C. for 0.5 hours. Subsequently, triisopropylsilyl chloride (0.35 mL, 1.61 mmol) was added dropwise and the mixture was stirred at room temperature for 4 hours. After cooling to 0° C., water was added dropwise and the mixture was separated with ethyl acetate. Ethyl acetate was added to the aqueous layer and extracted again, and then the organic layers were combined and washed with saturated brine. After evaporating the solvent under reduced pressure, the residue was purified with a silica gel column and dried under reduced pressure to obtain the title compound (272 mg, yield 80%).

Mass(ESI):m/zcalcdforC19H28FNNaSi[M+Na]+:340.19;found:340.16;1H-NMR(400MHz,CDCl3)δ(ppm):1.01(d,J=6.9Hz,18H),1.13-1.21(m,3H),6.25(dd,J=3.2,1.2Hz,1H),6.37(t,J=3.2Hz,1H),6.93(dd,J=2.8,2.0Hz,1H),7.03-7.12(m,2H),7.29-7.37(m,2H). Mass (ESI): m / zcalcdforC19H28FNNaSi [M + Na] +: 340.19; found: 340.16; 1H-NMR (400MHz, CDCl3) δ (ppm): 1.01 (d, J = 6.9Hz, 18H) , 1.13-1.21 (m, 3H), 6.25 (dd, J=3.2, 1.2Hz, 1H), 6.37 (t, J=3.2Hz, 1H), 6. 93 (dd, J=2.8, 2.0 Hz, 1H), 7.03-7.12 (m, 2H), 7.29-7.37 (m, 2H).

実施例3
5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドの製造
2-(2-フルオロフェニル)-1-(トリイソプロピルシリル)-1H-ピロ-ル(100mg,0.32mmol)のジクロロメタン(3.0mL)溶液に氷冷下Vilsmeier試薬(123mg,0.96mmol)を加え40℃で0.5時間攪拌した。溶媒を減圧下留去した後に水酸化ナトリウム水溶液(1.0M,3mL)を加え室温で6時間撹拌し、酢酸エチルを加え分液した。水層に酢酸エチルを加え再度抽出した後、有機層を合わせ飽和食塩水で洗浄した。シリカゲルカラムで精製し減圧下乾燥することにより表題化合物(48mg,収率80%)を得た。
Example 3
Preparation of 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole (100mg, 0.32mmol) Under ice-cooling, Vilsmeier reagent (123 mg, 0.96 mmol) was added to a dichloromethane (3.0 mL) solution of and stirred at 40° C. for 0.5 hour. After evaporating the solvent under reduced pressure, an aqueous sodium hydroxide solution (1.0 M, 3 mL) was added, the mixture was stirred at room temperature for 6 hours, and ethyl acetate was added to separate the layers. Ethyl acetate was added to the aqueous layer and extracted again, and then the organic layers were combined and washed with saturated brine. Purification with a silica gel column and drying under reduced pressure gave the title compound (48 mg, yield 80%).

Mass(ESI):m/zcalcdforC11H8FNNaO[M+Na]+:212.05;found:212.03;1H-NMR(400MHz,CDCl3)δ(ppm):7.07(dd,J=2.0,1.2Hz,1H),7.12-7.26(m,3H),7.53(dd,J=2.8,1.2Hz,1H),7.64(dt,J=7.6,1.6Hz,1H),9.45(brs,1H),9.86(s,1H). Mass (ESI): m / zcalcdfor C11H8FNNaO [M + Na] +: 212.05; found: 212.03; 1H-NMR (400 MHz, CDCl3) δ (ppm): 7.07 (dd, J = 2.0, 1. 2Hz, 1H), 7.12-7.26 (m, 3H), 7.53 (dd, J = 2.8, 1.2Hz, 1H), 7.64 (dt, J = 7.6, 1 .6Hz, 1H), 9.45 (brs, 1H), 9.86 (s, 1H).

実施例4
5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドの製造
水素化ナトリウム(60%流動パラフィンに分散、1.2g,30.0mmol)と4-メチルテトラヒドロピラン(10mL)の懸濁液に氷冷下ピロ-ル(2.1mL,30.0mmol)を滴下し0.5時間撹拌した後、塩化亜鉛(4.1g,30.0mmol)を加え室温で0.5時間攪拌した。続いて酢酸パラジウム(11mg,0.05mmol)、2-(ジ-tert-ブチルホスフィノ)ビフェニル(15mg,0.05mmol)及び1-フルオロ-2-ヨ-ドベンゼン(1.1mL,10.0mmol)を加え、100℃で0.5時間撹拌した。反応混合物を0℃で冷却しつつ28%アンモニア水を滴下し、不溶物をろ過した後、酢酸エチルで分液した。減圧下溶媒を留去後、2-(2-フルオロフェニル)-1H-ピロ-ルを粗生成物として得た。
水素化ナトリウム(60%流動パラフィンに分散,600mg,15mmol)とテトラヒドロフラン(10mL)及びジメチルイミダゾリジノン(2mL)の懸濁液に得られた2-(2-フルオロフェニル)-1H-ピロ-ルの粗生成物のテトラヒドロフラン(2mL)溶液を氷冷下滴下し0.5時間撹拌した。続いてトリイソプロピルシリルクロリド(3.2mL,15mmol)を滴下し室温で2時間撹拌した。0℃まで冷却しつつ水を滴下し酢酸エチルで分液した。減圧下溶媒を留去後、ヘプタンと水で再度分液操作を行い減圧下溶媒を留去することにより、2-(2-フルオロフェニル)-1-(トリイソプロピルシリル)-1H-ピロ-ルを粗生成物として得た。
得られた2-(2-フルオロフェニル)-1-(トリイソプロピルシリル)-1H-ピロ-ルの粗生成物のジクロロメタン(50mL)溶液に氷冷下Vilsmeier試薬(3.8g,30mmol)を加え40℃で0.5時間攪拌した。溶媒を減圧下留去した後に水酸化ナトリウム水溶液(1.0M,100mL)を加え室温で6時間撹拌し、酢酸エチルを加え分液した。有機層を飽和食塩水で洗浄後、減圧下溶媒を留去した。ヘプタン及び酢酸エチルで再結晶を行い、減圧下乾燥することにより表題化合物(1.34g,収率70%)を得た。
Example 4
Preparation of 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde sodium hydride (dispersed in 60% liquid paraffin, 1.2 g, 30.0 mmol) and 4-methyltetrahydropyran (10 mL). Pyrrole (2.1 mL, 30.0 mmol) was added dropwise to the suspension under ice cooling and stirred for 0.5 hours, then zinc chloride (4.1 g, 30.0 mmol) was added and stirred at room temperature for 0.5 hours. bottom. followed by palladium acetate (11 mg, 0.05 mmol), 2-(di-tert-butylphosphino)biphenyl (15 mg, 0.05 mmol) and 1-fluoro-2-iodobenzene (1.1 mL, 10.0 mmol) was added and stirred at 100° C. for 0.5 hours. While cooling the reaction mixture at 0° C., 28% aqueous ammonia was added dropwise, insoluble matter was filtered, and the mixture was separated with ethyl acetate. After evaporating the solvent under reduced pressure, 2-(2-fluorophenyl)-1H-pyrrole was obtained as a crude product.
2-(2-fluorophenyl)-1H-pyrrole obtained in a suspension of sodium hydride (60% dispersed in liquid paraffin, 600 mg, 15 mmol) in tetrahydrofuran (10 mL) and dimethylimidazolidinone (2 mL). A solution of the crude product in tetrahydrofuran (2 mL) was added dropwise under ice-cooling, and the mixture was stirred for 0.5 hour. Subsequently, triisopropylsilyl chloride (3.2 mL, 15 mmol) was added dropwise and the mixture was stirred at room temperature for 2 hours. Water was added dropwise while cooling to 0° C., and the mixture was separated with ethyl acetate. After distilling off the solvent under reduced pressure, separation was performed again with heptane and water, and the solvent was distilled off under reduced pressure to obtain 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole. was obtained as a crude product.
Vilsmeier reagent (3.8 g, 30 mmol) was added under ice-cooling to a dichloromethane (50 mL) solution of the obtained crude product of 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole. Stir at 40° C. for 0.5 hours. After evaporating the solvent under reduced pressure, an aqueous sodium hydroxide solution (1.0 M, 100 mL) was added, the mixture was stirred at room temperature for 6 hours, and ethyl acetate was added to separate the layers. After the organic layer was washed with saturated brine, the solvent was distilled off under reduced pressure. Recrystallization was performed with heptane and ethyl acetate, and the title compound (1.34 g, yield 70%) was obtained by drying under reduced pressure.

実施例5
5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-カルボキシアルデヒドの製造
水素化ナトリウム(60%流動パラフィンに分散,32mg,0.79mmol)とテトラヒドロフラン(2mL)の懸濁液に氷冷下5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒド(100mg,0.53mmol)のテトラヒドロフラン(2mL)溶液を滴下し0.5時間撹拌した後、15-クラウン-5-エ-テル(0.16mL,0.79mmol)を加え0℃で0.5時間攪拌した。続いてピリジン-3-スルホニルクロリド(95μL,0.79mmol)を添加し、0℃で0.5時間攪拌した。さらにピリジン-3-スルホニルクロリド(95μL,0.79mmol)を加え、0℃で0.5時間攪拌した。水を滴下し酢酸エチルで分液した。水層に酢酸エチルを加え再度抽出した後、有機層を合わせ飽和食塩水で洗浄した。減圧下溶媒を留去後、シリカゲルカラムで精製し減圧下乾燥することにより表題化合物(167mg,収率95%)を得た。
Example 5
Preparation of 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-carboxaldehyde sodium hydride (dispersed in 60% liquid paraffin, 32 mg, 0.79 mmol) and To a suspension of tetrahydrofuran (2 mL) was added dropwise a solution of 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde (100 mg, 0.53 mmol) in tetrahydrofuran (2 mL) under ice cooling. After stirring for 1 hour, 15-crown-5-ether (0.16 mL, 0.79 mmol) was added and stirred at 0°C for 0.5 hour. Pyridine-3-sulfonyl chloride (95 μL, 0.79 mmol) was then added and stirred at 0° C. for 0.5 hours. Further, pyridine-3-sulfonyl chloride (95 μL, 0.79 mmol) was added, and the mixture was stirred at 0° C. for 0.5 hours. Water was added dropwise, and the mixture was separated with ethyl acetate. Ethyl acetate was added to the aqueous layer and extracted again, and then the organic layers were combined and washed with saturated brine. After evaporating the solvent under reduced pressure, the residue was purified with a silica gel column and dried under reduced pressure to obtain the title compound (167 mg, yield 95%).

Mass(ESI):m/zcalcdforC16H11FN2NaO3S「M+Na」+:353.04;found:353.00;1H-NMR(400MHz,CDCl3)δ(ppm):6.68(d,J=1.7Hz,1H),7.01-7.05(m,1H),7.16-7.18(m,2H),7.37-7.40(m,1H),7.45-7.51(m,1H),7.69-7.72(m,1H),8.15(d,J=1.8Hz,1H),8.58(d,J=1.7Hz,1H),8.82(dd,J=4.8,1.5Hz,1H),9.90(s,1H). Mass (ESI): m / zcalcdfor C16H11FN2NaO3S "M + Na" +: 353.04; found: 353.00; 1H-NMR (400MHz, CDCl3) δ (ppm): 6.68 (d, J = 1.7Hz, 1H) , 7.01-7.05 (m, 1H), 7.16-7.18 (m, 2H), 7.37-7.40 (m, 1H), 7.45-7.51 (m, 1H), 7.69-7.72 (m, 1H), 8.15 (d, J = 1.8Hz, 1H), 8.58 (d, J = 1.7Hz, 1H), 8.82 ( dd, J = 4.8, 1.5 Hz, 1H), 9.90 (s, 1H).

実施例6
1-[5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-イル]-N-メチルメタンアミンフマル酸塩の製造
5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-カルボキシアルデヒド(100mg,0.30mmol)のメタノ-ル(3mL)溶液に室温でメチルアミンのメタノ-ル溶液(2.0M,1.06mL,2.12mmol)を滴下し、0.5時間攪拌した。0℃に冷却し、水素化ホウ素ナトリウム(34mg,0.91mmol)を加え0.5時間攪拌した。0℃で1規定塩酸(3mL)を滴下し、室温で0.5時間攪拌した。飽和重曹水、酢酸エチルを加え分液した。水層に酢酸エチルを加え再度抽出した後、有機層を合わせて飽和食塩水で洗浄した。有機層を濃縮した後、酢酸エチル(3mL)を加え、フマル酸(39mg,0.30mmol)のメタノ-ル(0.3mL)溶液を添加した。室温で30分間攪拌後、析出した結晶をろ過し、酢酸エチルとメタノ-ルで洗浄し、粗生成物を得た。得られた粗結晶をメタノ-ル及び水から再結晶し、析出した結晶をろ取後減圧下乾燥することにより表題化合物(90mg,収率64%)を得た。
Example 6
Preparation of 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate 5-(2-fluoro Phenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-carboxaldehyde (100 mg, 0.30 mmol) in methanol (3 mL) was added at room temperature to methanol solution of methylamine ( 2.0 M, 1.06 mL, 2.12 mmol) was added dropwise and stirred for 0.5 hours. After cooling to 0° C., sodium borohydride (34 mg, 0.91 mmol) was added and stirred for 0.5 hour. 1N Hydrochloric acid (3 mL) was added dropwise at 0° C., and the mixture was stirred at room temperature for 0.5 hours. Saturated sodium bicarbonate water and ethyl acetate were added to separate the layers. After adding ethyl acetate to the aqueous layer and extracting again, the organic layers were combined and washed with saturated brine. After concentrating the organic layer, ethyl acetate (3 mL) was added, and a solution of fumaric acid (39 mg, 0.30 mmol) in methanol (0.3 mL) was added. After stirring at room temperature for 30 minutes, precipitated crystals were filtered and washed with ethyl acetate and methanol to obtain a crude product. The obtained crude crystals were recrystallized from methanol and water, and the precipitated crystals were collected by filtration and dried under reduced pressure to obtain the title compound (90 mg, yield 64%).

Mass(ESI):m/zcalcdforC17H17FN3NaO2S「M+H」+:346.09;found:346.11;1H-NMR(400MHz,DMSO-d6)δ(ppm):2.39(s,3H),3.76(s,2H),6.44(d,J=2.0Hz,1H),6.47(s,2H),7.10-7.13(m,1H),7.20-7.26(m,2H),7.50-7.56(m,1H),7.60-7.67(m,2H),7.85-7.89(m,1H),8.56(d,J=2.8Hz,1H),8.87-8.89(m,1H).3H未検出。
Mass (ESI): m / zcalcdfor C17H17FN3NaO2S "M + H" +: 346.09; found: 346.11; 1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.39 (s, 3H), 3.76 (s, 2H), 6.44 (d, J=2.0Hz, 1H), 6.47 (s, 2H), 7.10-7.13 (m, 1H), 7.20-7.26 (m, 2H), 7.50-7.56 (m, 1H), 7.60-7.67 (m, 2H), 7.85-7.89 (m, 1H), 8.56 (d , J=2.8Hz, 1H), 8.87-8.89(m, 1H). 3H not detected.

実施例7
5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドの製造
水素化ナトリウム(60%流動パラフィンに分散、8.8g,220.0mmol)と4-メチルテトラヒドロピラン(100mL)の懸濁液に氷冷下ピロ-ル(15.7mL,220.0mmol)を滴下し0.5時間撹拌した後、塩化亜鉛(30.3g,220.0mmol)を加え室温で0.5時間攪拌した。続いて酢酸パラジウム(56.1mg,0.25mmol)、2-(ジ-tert-ブチルホスフィノ)ビフェニル(74.6mg,0.25mmol)及び1-フルオロ-2-ヨ-ドベンゼン(11.5mL,100.0mmol)を加え、約100℃で1時間撹拌した。氷冷下、反応混合物に水酸化ナトリウム水溶液(5.0N,220.0mmol)を滴下し、室温で0.5時間攪拌した。不溶物をろ過、トルエン(100mL)を用いて洗浄した後、有機層を分離して水層をトルエン(100mL)を用いて抽出した。有機層を合わせ蒸留水(167mL)及び飽和食塩水(167mL)で洗浄した。減圧下溶媒を留去後、残渣にトルエン(167mL)を加えた。減圧下溶媒を留去することにより、2-(2-フルオロフェニル)-1H-ピロ-ルを粗生成物(20.9g)として得た。
水素化ナトリウム(60%流動パラフィンに分散,4.4g,110.0mmol)とテトラヒドロフラン(100mL)及びジメチルイミダゾリジノン(32.6mL,300.0mmol)の懸濁液に得られた2-(2-フルオロフェニル)-1H-ピロ-ルの粗生成物のテトラヒドロフラン(10mL)溶液を氷冷下滴下し、テトラヒドロフラン(10mL)で洗いこみ、0.5時間撹拌した。続いてトリイソプロピルシリルクロリド(23.5mL,110.0mmol)を滴下し室温で1時間撹拌した。氷浴下、蒸留水(17mL)を滴下し、さらに蒸留水(167mL)を加えた。酢酸エチル(84mL)を用いて2回抽出を行い、蒸留水(167mL)及び飽和食塩水(167mL)で洗浄した。減圧下溶媒を留去後、残渣にトルエン(167mL)を加えた。減圧下溶媒を留去後、減圧下溶媒を留去することにより、2-(2-フルオロフェニル)-1-(トリイソプロピルシリル)-1H-ピロ-ルを粗生成物(45.2g)として得た。
ジクロロメタン(100mL)に塩化オキサリル(17.2mL,200.0mmol)を加え、DMF(15.5mL,200.0mmol)を氷冷下滴下し、0.5時間撹拌した。得られた2-(2-フルオロフェニル)-1-(トリイソプロピルシリル)-1H-ピロ-ルの粗生成物の4-メチルテトラヒドロピラン(100mL)溶液を一度で加え約50℃で3時間攪拌した。氷冷下、水酸化ナトリウム水溶液(5.0M,100mL)を加え室温で終夜撹拌した。有機層を分離し、水層を酢酸エチル(200mL)で分液した。有機層を合わせ、飽和食塩水(200mL)で洗浄後、減圧下溶媒を留去した。得られた固体残渣に酢酸エチル(47mL)を加え、約70℃にて溶解後、ヘプタン(300mL)を加えた。室温下放冷後、氷浴下で1時間撹拌し、析出した結晶をろ取、冷却した酢酸エチル:ヘプタン(1:6,70mL)で洗浄した。減圧下にて50℃、1.5時間乾燥することにより表題化合物(13.6g,収率72%)を得た。
Example 7
Preparation of 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde Sodium hydride (dispersed in 60% liquid paraffin, 8.8 g, 220.0 mmol) and 4-methyltetrahydropyran (100 mL) Pyrrole (15.7 mL, 220.0 mmol) was added dropwise to the suspension under ice cooling and stirred for 0.5 hours, then zinc chloride (30.3 g, 220.0 mmol) was added and stirred at room temperature for 0.5 hours. bottom. followed by palladium acetate (56.1 mg, 0.25 mmol), 2-(di-tert-butylphosphino)biphenyl (74.6 mg, 0.25 mmol) and 1-fluoro-2-iodobenzene (11.5 mL, 100.0 mmol) was added and stirred at about 100° C. for 1 hour. An aqueous sodium hydroxide solution (5.0 N, 220.0 mmol) was added dropwise to the reaction mixture under ice cooling, and the mixture was stirred at room temperature for 0.5 hours. After filtering the insoluble matter and washing with toluene (100 mL), the organic layer was separated and the aqueous layer was extracted with toluene (100 mL). The organic layers were combined and washed with distilled water (167 mL) and saturated brine (167 mL). After evaporating the solvent under reduced pressure, toluene (167 mL) was added to the residue. By evaporating the solvent under reduced pressure, 2-(2-fluorophenyl)-1H-pyrrole was obtained as a crude product (20.9 g).
The resulting 2-(2 A tetrahydrofuran (10 mL) solution of the crude product of -fluorophenyl)-1H-pyrrole was added dropwise under ice cooling, washed with tetrahydrofuran (10 mL), and stirred for 0.5 hour. Subsequently, triisopropylsilyl chloride (23.5 mL, 110.0 mmol) was added dropwise, and the mixture was stirred at room temperature for 1 hour. Distilled water (17 mL) was added dropwise under an ice bath, and further distilled water (167 mL) was added. Extraction was performed twice using ethyl acetate (84 mL) and washed with distilled water (167 mL) and saturated brine (167 mL). After evaporating the solvent under reduced pressure, toluene (167 mL) was added to the residue. After evaporating the solvent under reduced pressure, 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole was obtained as a crude product (45.2 g) by evaporating the solvent under reduced pressure. Obtained.
Oxalyl chloride (17.2 mL, 200.0 mmol) was added to dichloromethane (100 mL), DMF (15.5 mL, 200.0 mmol) was added dropwise under ice cooling, and the mixture was stirred for 0.5 hour. A solution of the obtained crude 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole in 4-methyltetrahydropyran (100 mL) was added at once and stirred at about 50° C. for 3 hours. bottom. An aqueous sodium hydroxide solution (5.0 M, 100 mL) was added under ice-cooling, and the mixture was stirred overnight at room temperature. The organic layer was separated and the aqueous layer was partitioned with ethyl acetate (200 mL). The organic layers were combined, washed with saturated brine (200 mL), and the solvent was distilled off under reduced pressure. Ethyl acetate (47 mL) was added to the obtained solid residue, and after dissolution at about 70° C., heptane (300 mL) was added. After allowing to cool to room temperature, the mixture was stirred in an ice bath for 1 hour, and the precipitated crystals were collected by filtration and washed with cooled ethyl acetate:heptane (1:6, 70 mL). The title compound (13.6 g, yield 72%) was obtained by drying at 50° C. under reduced pressure for 1.5 hours.

実施例8
5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドの製造(2-(2-フルオロフェニル)-1H-ピロ-ルからのワンポット合成)
2-(2-フルオロフェニル)-1H-ピロ-ル(10.0g,62.0mmol)の4-メチルテトラヒドロピラン(62mL)溶液にジメチルイミダゾリジノン(20.0mL,186mmol)を加えた後、水素化ナトリウム(60%流動パラフィンに分散,2.7g,68.2mmol)を氷冷下ゆっくりと加え10分間撹拌した。続いてトリイソプロピルシリルクロリド(14.6mL,68.2mmol)を滴下し氷冷下2時間撹拌した。塩化オキサリル(10.6mL,124mmol)とDMF(9.65mL,124mmol)から調整したVilsmeier試薬のジクロロメタン(90mL)溶液に、2-(2-フルオロフェニル)-1H-ピロ-ルの反応溶液を氷冷下一度で加え、4-メチルテトラヒドロピラン(20mL)で洗いこみ、約60℃で2時間攪拌した。氷冷下、水酸化ナトリウム水溶液(2.0M,310mL)を加え室温で終夜撹拌した。有機層を分離し、水層を酢酸エチル(120mL)で分液した。有機層を合わせ、飽和食塩水(120mL)で洗浄後、減圧下溶媒を留去した。得られた固体残渣に酢酸エチル(29mL)を加え、約70℃にて溶解後、ヘプタン(180mL)を加えた。室温下放冷後、氷浴下で1時間撹拌し、析出した結晶をろ取、冷却した酢酸エチル:ヘプタン(1:6,42mL)で洗浄した。減圧下にて50℃、1.5時間乾燥することにより表題化合物(8.30g,収率71%)を得た。
Example 8
Preparation of 5-(2-fluorophenyl)-1H-pyrrole-3-carboxaldehyde (one-pot synthesis from 2-(2-fluorophenyl)-1H-pyrrole)
After adding dimethylimidazolidinone (20.0 mL, 186 mmol) to a solution of 2-(2-fluorophenyl)-1H-pyrrole (10.0 g, 62.0 mmol) in 4-methyltetrahydropyran (62 mL), Sodium hydride (dispersed in 60% liquid paraffin, 2.7 g, 68.2 mmol) was slowly added under ice cooling and stirred for 10 minutes. Subsequently, triisopropylsilyl chloride (14.6 mL, 68.2 mmol) was added dropwise, and the mixture was stirred under ice cooling for 2 hours. The reaction solution of 2-(2-fluorophenyl)-1H-pyrrole was added to a solution of Vilsmeier reagent in dichloromethane (90 mL) prepared from oxalyl chloride (10.6 mL, 124 mmol) and DMF (9.65 mL, 124 mmol). The mixture was added all at once under cooling, washed with 4-methyltetrahydropyran (20 mL), and stirred at about 60° C. for 2 hours. An aqueous sodium hydroxide solution (2.0 M, 310 mL) was added under ice-cooling, and the mixture was stirred overnight at room temperature. The organic layer was separated and the aqueous layer was partitioned with ethyl acetate (120 mL). The organic layers were combined, washed with saturated brine (120 mL), and the solvent was distilled off under reduced pressure. Ethyl acetate (29 mL) was added to the obtained solid residue, and after dissolution at about 70° C., heptane (180 mL) was added. After allowing to cool to room temperature, the mixture was stirred in an ice bath for 1 hour, and the precipitated crystals were collected by filtration and washed with cooled ethyl acetate:heptane (1:6, 42 mL). The title compound (8.30 g, yield 71%) was obtained by drying under reduced pressure at 50°C for 1.5 hours.

Claims (8)

下記式(I):
Figure 0007227925000011
で表されるピロ-ル誘導体において、ピロ-ル環の窒素原子に保護基を導入し、
下記一般式(II):
Figure 0007227925000012
(式中、Pは保護基を表す)で表されるN保護ピロ-ル誘導体を得、さらにホルミル化により下記一般式(III)
Figure 0007227925000013
で表されるピロ-ル-3-カルボキシアルデヒド誘導体を得、さらに脱保護反応することを特徴とする、下記式(IV)
Figure 0007227925000014
で表される5-(2-フルオロフェニル)-1H-ピロ-ル-3-カルボキシアルデヒドの製造方法。
Formula (I) below:
Figure 0007227925000011
In the pyrrole derivative represented by, a protecting group is introduced to the nitrogen atom of the pyrrole ring,
The following general formula (II):
Figure 0007227925000012
(Wherein, P represents a protecting group) to obtain an N-protected pyrrole derivative represented by the following general formula (III) by formylation
Figure 0007227925000013
A pyrrole-3-carboxaldehyde derivative represented by the following formula (IV), characterized in that it is further deprotected.
Figure 0007227925000014
A method for producing 5-(2-fluorophenyl)-1H-pyrrol-3-carboxaldehyde represented by
前記Pで表される保護基が、シリル系保護基である請求項1記載の製造方法。 2. The production method according to claim 1, wherein the protecting group represented by P is a silyl protecting group. 前記Pで表される保護基が、トリイソプロピルシリル基である請求項1又は2記載の製造方法。 3. The production method according to claim 1 or 2, wherein the protective group represented by P is a triisopropylsilyl group. 記式(I)のピロール誘導体が、
下記一般式(V):
Figure 0007227925000015
(式中、Lは脱離基を表す)で表されるオルトフルオロベンゼン誘導体を、金属触媒存在下、ピロ-ルと反応させることにより得られたものである請求項1~3のいずれか一項に記載の製造方法。
The pyrrole derivative of formula (I) is
The following general formula (V):
Figure 0007227925000015
(wherein L represents a leaving group), obtained by reacting an orthofluorobenzene derivative represented by the formula with pyrrole in the presence of a metal catalyst. The manufacturing method described in the item .
前記金属触媒がパラジウム触媒である請求項4記載の製造方法。 5. The production method according to claim 4, wherein said metal catalyst is a palladium catalyst. 求項1~5のいずれか一項に記載の製造方法により前記式(IV)で表される化合物次いで前記式(IV)で表される化合物を、無機塩基または有機塩基の存在下、ピリジン-3-スルホニルクロリドまたはその塩と反応させ、下記式(VI)
Figure 0007227925000016
で表されるピロ-ル誘導体を得、さらにメチルアミンと縮合させた後、還元反応することを特徴とする、下記式(VII):
Figure 0007227925000017
で表される1-[5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-イル]-N-メチルメタンアミンの製造方法。
The compound represented by the formula (IV) is obtained by the production method according to any one of claims 1 to 5 , and then the compound represented by the formula (IV) is treated in the presence of an inorganic base or an organic base. Below, it is reacted with pyridine-3-sulfonyl chloride or a salt thereof, and the following formula (VI)
Figure 0007227925000016
The following formula (VII), characterized in that a pyrrole derivative represented by is obtained, further condensed with methylamine, and then subjected to a reduction reaction:
Figure 0007227925000017
A method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine represented by
請求項6に記載の製造方法により前記式(VII)で表される化合物を得、フマル酸を添加することを特徴とする1-[5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロ-ル-3-イル]-N-メチルメタンアミンモノフマル酸塩の製造方法。 1-[5-(2-fluorophenyl)-1-(pyridine), wherein the compound represented by the formula (VII) is obtained by the production method according to claim 6, and fumaric acid is added. -3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate. 2-(2-フルオロフェニル)-1-(トリイソプロピルシリル)-1H-ピロ-ル。2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole.
JP2019562062A 2017-12-27 2018-12-26 Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate Active JP7227925B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017251749 2017-12-27
JP2017251749 2017-12-27
PCT/JP2018/047697 WO2019131695A1 (en) 2017-12-27 2018-12-26 Production method for 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1h-pyrrol-3-yl]-n-methylmethanamine monofumarate

Publications (2)

Publication Number Publication Date
JPWO2019131695A1 JPWO2019131695A1 (en) 2021-01-14
JP7227925B2 true JP7227925B2 (en) 2023-02-22

Family

ID=67063705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019562062A Active JP7227925B2 (en) 2017-12-27 2018-12-26 Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate

Country Status (4)

Country Link
JP (1) JP7227925B2 (en)
KR (2) KR102500124B1 (en)
CN (1) CN111527067A (en)
WO (1) WO2019131695A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113549054B (en) * 2020-04-23 2024-03-15 鲁南制药集团股份有限公司 Vonoprazan fumarate intermediate and preparation method thereof
CN114573560B (en) * 2022-03-17 2024-02-06 日照正济药业有限公司 Preparation method of voronoi fumarate

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008522952A (en) 2005-08-30 2008-07-03 武田薬品工業株式会社 1-Heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
WO2010098351A1 (en) 2009-02-25 2010-09-02 武田薬品工業株式会社 Process for producing pyrrole compound
CN105440019A (en) 2015-12-17 2016-03-30 昆明贵研药业有限公司 Preparation method of drug for treating gastric acid related diseases
CN106146466A (en) 2016-06-30 2016-11-23 珠海赛隆药业股份有限公司(长沙)医药研发中心 Vonoprazan fumarate intermediate, its preparation method and the method for preparation Vonoprazan fumarate
CN106187852A (en) 2016-07-07 2016-12-07 江西同和药业股份有限公司 A kind of preparation method of Vonoprazan fumarate intermediate
CN106366071A (en) 2016-08-22 2017-02-01 山东金城医药股份有限公司 Vonoprazan fumarate preparation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819494B2 (en) 1978-11-06 1983-04-18 トヨタ自動車株式会社 Passive seat belt device
IL87222A (en) * 1987-07-29 1993-04-04 American Cyanamid Co Arylpyrroles, methods for thepreparation thereof andinsecticidal, acaricidal andnematicidal compositionscontaining them
US5101042A (en) 1990-12-11 1992-03-31 American Cyanamid Company Process for the preparation of insecticidal, nematicidal and acaricidal 2-halo-3-substituted-5-arylpyrrole compounds

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008522952A (en) 2005-08-30 2008-07-03 武田薬品工業株式会社 1-Heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
WO2010098351A1 (en) 2009-02-25 2010-09-02 武田薬品工業株式会社 Process for producing pyrrole compound
CN105440019A (en) 2015-12-17 2016-03-30 昆明贵研药业有限公司 Preparation method of drug for treating gastric acid related diseases
CN106146466A (en) 2016-06-30 2016-11-23 珠海赛隆药业股份有限公司(长沙)医药研发中心 Vonoprazan fumarate intermediate, its preparation method and the method for preparation Vonoprazan fumarate
CN106187852A (en) 2016-07-07 2016-12-07 江西同和药业股份有限公司 A kind of preparation method of Vonoprazan fumarate intermediate
CN106366071A (en) 2016-08-22 2017-02-01 山东金城医药股份有限公司 Vonoprazan fumarate preparation method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZWEIG Joshua E., et al.,Isomer-Specific Hydrogen Bonding as a Design Principle for Bidirectionally Quantitative and Redshift,Journal of the American Chemical Society,2017年07月,Vol.139(32),p.10956-10959

Also Published As

Publication number Publication date
JPWO2019131695A1 (en) 2021-01-14
KR20200096598A (en) 2020-08-12
CN111527067A (en) 2020-08-11
KR20220127369A (en) 2022-09-19
WO2019131695A1 (en) 2019-07-04
KR102443292B1 (en) 2022-09-14
KR102500124B1 (en) 2023-02-14

Similar Documents

Publication Publication Date Title
WO1999001420A1 (en) Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process
JP7227925B2 (en) Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate
JP3173602B2 (en) Novel intermediate for the production of enyne derivatives and its production method
CN110845482B (en) Process for preparing indole compounds
JPH06263699A (en) Preparation of l-5-(2-acetoxy-propyonyl- amino)-2,4,6-triiodo-isophthaloyl dichloride
CN113861167A (en) Preparation method of Voranolan fumarate
CN114641468A (en) Process for the synthesis of the sodium salt of 4- [ [ (1R) -2- [5- (2-fluoro-3-methoxyphenyl) -3- [ [ 2-fluoro-6- (trifluoromethyl) -phenyl ] methyl ] -3, 6-dihydro-4-methyl-2, 6-dioxo-1 (2H) -pyrimidinyl ] -1-phenylethyl ] amino ] -butyric acid (ELAGOLIX sodium salt) and intermediates of said process
WO2021120953A1 (en) Method for synthesizing 1,7-naphthyridine derivative
CN106957318B (en) Condensed polycyclic indoline compound, preparation method, pharmaceutical composition and application thereof
TWI809489B (en) Processes and intermediates for the preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamide
JP2020536898A (en) Process for preparing spiro derivatives
JP2004238322A (en) Method for producing (r)-3-aminopentanenitrile methanesulfonic acid salt
CN110498808B (en) Intermediate for synthesizing (2S,3R) -3-substituted phenyl pyrrolidine-2-carboxylic acid and preparation method and application thereof
CN111187197B (en) Synthesis method of Tezacaftor intermediate
CN107556237B (en) Preparation method of 3- (2-phenethyl) -2-pyridine carboxamide compound
US20230025246A1 (en) Process for preparing chroman compounds
WO2015163446A1 (en) Method for producing imidazole compound
JP2022035954A (en) N-boc-lactam derivative and method for producing the same, and method for producing cyclic amine derivative
JP2019196359A (en) Chemical process for preparing pyrimidine derivatives and intermediates thereof
WO2005063678A1 (en) Process for producing phenylacetic acid derivative
JP2021075535A (en) Chemical process for preparing pyrimidine derivatives and intermediates thereof
JP3727989B2 (en) Method for producing indole derivatives
CN111100112A (en) Benzothiophene derivative and process for producing the same
WO2005026119A1 (en) Method for producing sulfone amide-containing indole compound
KR20070093656A (en) Novel processes for the preparation of losartan, and a benzylimidazol derivative as useful intermediate for preparation thereof

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20200629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200629

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211214

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230117

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230210

R150 Certificate of patent or registration of utility model

Ref document number: 7227925

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150